Method of treating alvelor bone loss through the use of anti-sclerostin antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9913900
SERIAL NO

15494121

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a method of treating alveolar bone loss involving administration of a sclerostin inhibitor to a subject in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • AMGEN INC.;THE REGENTS OF THE UNIVERSITY OF MICHIGAN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Giannobile, William V Ann Arbor, US 6 56
Ke, Hua Zhu Newbury Park, US 21 195
Liu, Min Thousand Oaks, US 262 2438

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00